Edition:
United Kingdom

Rhythm Pharmaceuticals Inc (RYTM.OQ)

RYTM.OQ on NASDAQ Stock Exchange Global Market

29.09USD
8 Dec 2017
Change (% chg)

-- (--)
Prev Close
$29.09
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$33.80
52-wk Low
$21.38

Chart for

About

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders. The Company’s lead peptide product candidate is setmelanotide, a potent,... (more)

Overall

Beta: --
Market Cap(Mil.): $685.07
Shares Outstanding(Mil.): 27.13
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.65 16.44
EPS (TTM): -- -- --
ROI: -- 2.35 10.62
ROE: -- 2.95 14.20

BRIEF-Rhythm Pharmaceuticals reports Q3 loss of $1.78/shr

* Rhythm Pharmaceuticals reports third quarter 2017 financial results

14 Nov 2017

Earnings vs. Estimates